Ulta Beauty to Report Q2 Earnings: Here's What You Should Expect

Ulta Beauty's fiscal Q2 2025 outlook anticipates revenues of $2.65 billion, marking a 4% year-over-year increase, while EPS is estimated at $4.98, a 6% decline from the prior-year quarter despite a recent 2.3% upward revision. Key growth drivers include omnichannel strategies, digital innovation, and strong skincare performance, yet the company faces headwinds from rising selling, general, and administrative expenses, increased supply-chain costs, and a persistent decline in its makeup category. Despite these operational pressures, the Zacks model, leveraging a positive Earnings ESP of +1.19% and a Zacks Rank #2, predicts Ulta will exceed its Q2 earnings estimates.

Analysis

Ulta Beauty is approaching its fiscal second-quarter earnings with a mixed but quantitatively favorable outlook. Consensus estimates project a 4% year-over-year revenue increase to $2.65 billion, yet anticipate a 6% decline in earnings per share to $4.98. This expected margin compression is a primary concern, attributed to a significant rise in SG&A expenses, which are forecasted to increase by 180 basis points to 27.1% of net sales due to strategic investments, advertising, and payroll costs. Further pressure stems from elevated supply-chain expenses and a persistent decline in the makeup category. Despite these headwinds, several positive drivers support the company's performance, including a robust omnichannel strategy, AI-driven personalization enhancing customer engagement, and notable strength in the high-growth skincare segment, led by brands like Sol de Janeiro and Tatcha. Crucially, the Zacks proprietary model predicts an earnings beat, supported by a positive Earnings ESP of +1.19%, a Zacks Rank #2 (Buy), and a historical precedent of delivering an average 11.9% trailing four-quarter earnings surprise.

Key Decisions for Investors

• Given the positive quantitative signals from the Zacks model and a strong history of earnings surprises, investors might consider a tactical long position ahead of the report, anticipating an EPS beat.
• Investors should scrutinize the earnings release for margin performance, specifically whether SG&A expenses as a percentage of sales come in below the feared 180 basis point increase, as this will be a key determinant of the post-earnings stock reaction.
• Pay close attention to the commentary on segment performance; continued outperformance in the high-growth skincare category could signal a successful strategic pivot that mitigates the risk from the ongoing decline in the makeup segment.
• It is critical to evaluate management's forward guidance on cost pressures and their outlook for the makeup category, as this will heavily influence the stock's trajectory beyond the immediate earnings announcement.